Hemex

AI Verified

Location

Switzerland


Investor type

Family Office


Current investment status

00 00 00


Website

https://hemex.eu


Linkedin

00 00 00


Submission link

00 00 00


Company address

14 Grammetstrasse, 4410 Liestal, Canton of Basel-Landschaft, Switzerland


Founding year

2011


Twitter

00 00 00


Facebook

00 00 00

Criteria Requirements Match
Regions Northern Europe, Western Europe
00
Countries
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Sector
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Impact Area
00 00 00
Stage Seed, Series A, Series B, Pre-Seed
00
Ticket size
00 00 00
-
00 00 00
USD
00
Monetization model
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Product readiness
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Client types
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Min. revenue
00 00 00
USD
00
Other
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
-

Unlock Free Premium Insights

Discover how well you match with this investor and reach out on the Raise Better platform.

  • Advanced matching algorithm
  • Detailed compatibility scores
  • Priority investor access
Create Free Account

Company description

Hemex operates as a specialized Contract Research Organization that collaborates with European biotechnology and medical technology enterprises to streamline their product clinical development processes. Strategically headquartered in Basel, Switzerland—a renowned life sciences center—with additional operations in Germany, Benelux countries, and Colombia, the organization is ideally positioned to coordinate and execute multinational clinical trials and research initiatives across diverse geographic regions.

The company delivers a comprehensive range of clinical development services, encompassing rigorous quality management systems and expert regulatory guidance. Hemex distinguishes itself through its commitment to transparent communication and accessibility, maintaining close proximity to clients while ensuring all project stakeholders remain informed throughout the development lifecycle. This client-centric approach enables more efficient decision-making and helps navigate the complex regulatory landscapes across different markets.

With deep expertise in European regulatory frameworks and clinical trial management, Hemex has established itself as a valuable partner for emerging and established life science companies seeking to advance their innovations through clinical validation. The organization's multinational presence allows it to leverage local knowledge and relationships with clinical sites, regulatory authorities, and healthcare systems across multiple jurisdictions, providing clients with streamlined access to diverse patient populations and markets.

Hemex's collaborative methodology emphasizes working alongside clients rather than simply for them, creating integrated teams that align closely with each company's specific objectives and timelines. This partnership model has proven particularly valuable for biotechnology and medical device developers navigating the critical phases between preclinical research and market approval. By providing tailored support throughout the clinical development journey, Hemex enables its clients to optimize resource allocation, accelerate development timelines, and ultimately increase their chances of bringing innovative healthcare solutions to patients.

Highlights

Partners with European Biotech & MedTech companies
Offers clinical development services across multiple regions

Ready to raise better?

Create your Free Account!

Frequently asked questions

Where is Hemex located?

Hemex maintains its global headquarters in Switzerland, serving as the strategic center for its operations. The company's primary corporate offices are located at 14 Grammetstrasse, 4410 Liestal, Canton of Basel-Landschaft, Switzerland.

What investment stages Hemex focuses on?

Hemex focuses its investment activities on companies operating in the following stages: Seed, Series A, Series B, Pre-Seed. Hemex provides strategic capital and expertise to support promising businesses at these critical phases of development.

Where does Hemex invest?

Hemex maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Northern Europe, Western Europe.

When was Hemex founded?

Hemex was established in 2011, marking the beginning of its journey as an investment firm.

What kind of investment firm is Hemex?

Hemex is the following type of investment firm: Family Office. The organization provides capital and strategic support to entrepreneurs and growing companies.